Inflammation and autoimmunity
An individualized medical approach for people living with persistent inflammation, symptoms associated with autoimmune conditions or chronic degenerative diseases who want to understand which complementary options may be considered within their plan.
Not everyone with inflammation needs the same treatment
Inflammation can arise in very different contexts. That is why we begin by reviewing the diagnosis, symptoms, current treatments, available test results, lifestyle and goals before considering any additional intervention.
We review the progression of symptoms, previous diagnoses, medications, prior treatments and clinical response.
We analyze the patient’s overall context and available test results to better understand where inflammation may be involved.
When there is an autoimmune diagnosis, the plan must consider the specific disease, its activity and the treatment prescribed by the doctors already caring for the patient.
Options are selected according to the clinical profile. There is no single protocol for everyone.
Treatments that may be part of the program
Depending on medical evaluation, CellNova may consider different supportive approaches. Selection and combinations depend on each patient’s clinical situation, goals and medical history.
Mesenchymal cells
Cell-based approaches are being investigated for specific diseases; findings cannot be generalized to all autoimmune conditions or all products. Research does not by itself establish that a specific product controls the disease or modifies its course. Any proposal requires specialist review of the evidence, risks and applicable authorizations.
Their inclusion in the plan is assessed after reviewing the diagnosis, medical history, current treatments and individual goals.
Learn more about mesenchymal cells →Exosomes and cell signaling
The study of cell signaling does not establish that an exosome-based product treats an autoimmune disease. Disease control or an effect on its course should not be claimed without clinical evidence specific to the product and indication.
The product’s origin, characterization and handling are an important part of the evaluation.
Learn about the secretome and exosomes →Medical ozone therapy
The available evidence does not establish ozone therapy as a treatment for autoimmune disease. Each proposed modality requires review of its specific evidence, risks, contraindications and applicable authorizations. Individual assessment does not replace that review.
- Major autohemotherapy
- Local ozone therapy
- Rectal insufflation
- Topical ozone
Personalized vitamins and supplementation
Supplementation is considered when nutritional needs or clinical indications have been identified. It does not replace treatment for an autoimmune disease or justify assuming an effect on inflammation or the course of the disease.
Selection is adjusted to the patient’s available test results, medical history, diet and goals.
Modalities that may be selected according to the case
The available evidence does not establish ozone therapy as a treatment for autoimmune disease. Each proposed modality requires review of its specific evidence, risks, contraindications and applicable authorizations. Individual assessment does not replace that review.
A procedure in which a quantity of blood is drawn, processed through an ozonation protocol and then reinfused.
Localized administration that may be considered when the clinical goal focuses on joints, tissues or other specific areas.
A modality included in the ozone therapy program when the doctor considers a systemic approach appropriate.
Use of ozonated products for certain situations involving skin and tissues.
We also aim to understand what may be influencing your case
Depending on the medical history, complementary tests may be considered to obtain more information before structuring the program.
May provide information on the composition and diversity of the microbiome within a digestive and inflammatory context.
Testing for food-related symptoms is selected according to the medical history and whether the test is validated for the specific clinical question.
In some patients, markers related to cortisol, hormonal metabolism and endocrine balance are reviewed.
The program also includes assessments related to mitochondrial function, oxidative stress and other markers when clinically indicated.
Supplementation tailored to test results and goals
Supplementation is considered when nutritional needs or clinical indications have been identified. It does not replace treatment for an autoimmune disease or justify assuming an effect on inflammation or the course of the disease.
Supplementation may be integrated into the plan when the doctor determines there is an appropriate indication.
May focus on goals related to energy, metabolism and general well-being.
Stress and rest may be part of the patient’s overall evaluation.
When appropriate, supplementation may be selected with consideration of hormonal test results and individual goals.
How we build the program
We review the diagnosis, symptoms, test results, medications and current treatments.
The doctor may request additional tests when they provide useful information for decision-making.
Depending on the case, the program may incorporate mesenchymal cells, exosomes, ozone therapy, supplementation or other strategies.
Clinical progress is reviewed throughout the process, and the plan may be adjusted when needed.
The goal is not to replace your current treatment
If you have a diagnosed autoimmune disease, CellNova’s options are evaluated within an individualized approach. You must not stop or change medications or treatments prescribed by your specialist on your own.
Frequently asked questions
Which treatments do you use for inflammation and autoimmunity?
The page discusses evaluation and approaches with different levels of evidence. Research into cell products or exosomes does not establish control of an autoimmune disease. Any proposal requires review of the specific evidence, risks and applicable authorizations, alongside the specialist’s treatment.
Does everyone receive the same treatments?
No. The program is selected according to the diagnosis, current status, medical history, medications, available test results and individual goals.
Do I need to stop the medications I already take?
You must not stop or change any medication on your own. Any change must be discussed with the doctors responsible for your treatment.
Does everyone with an autoimmune disease receive mesenchymal cells?
No. An autoimmune diagnosis does not by itself justify a cell product. Findings from one disease or product cannot be generalized to others. Specialist review of the specific evidence, risks and authorizations is required.
Why might additional tests be requested?
Because similar symptoms may have different contexts. Test results, together with the medical history, may provide additional information before determining which options make sense to consider.
Do these treatments guarantee control of an autoimmune disease?
No. A clinical response, disease control or a cure cannot be guaranteed. Research on immune modulation does not establish that a specific product changes the course of your disease. Do not replace treatment prescribed by your specialist.
Tell us your diagnosis and the treatment you are receiving
Our team can review your situation and explain which CellNova options may make sense to consider as part of an individual medical evaluation.
Educational information. The therapies described are not appropriate for everyone and do not replace treatment prescribed by a specialist. The availability and suitability of any intervention depend on an individual medical evaluation. Results may vary from patient to patient.Do not stop or change treatment prescribed by your specialist without consulting them. Research on immune modulation does not by itself establish control or a cure for an autoimmune disease. Any proposal should be reviewed with your specialist and does not replace care indicated for your diagnosis.
The information on this page is educational and does not replace an individual medical evaluation. Evidence, risks and regulatory status vary by intervention, product and proposed use. Research on a biological mechanism does not by itself establish that a treatment is safe or effective. A cure, regeneration or specific clinical outcomes are not guaranteed. Decisions require review of the applicable evidence, risks, alternatives and informed consent.